Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Sun Pharma Advanced Research Company Limited
Location
T. Score
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED

www.sunpharma.in

Active

Updated: 10 Jun 2024

Sun Pharma Advanced Research Company Limited, is a listed public company incorporated on 01 March, 2006. It is classified as a public limited company and is located in Vadodara, Gujarat. It's authorized share capital is INR 42.50 cr and the total paid-up capital is INR 32.45 cr.

Sun Pharma Advanced Research Company Limited's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2020. It's book networth has decreased by 106.29%.

Industry

Research and Development

Products

salmeterol-fluticasone DPI, Levetiracetam ER

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue

-57.94%

₹ GET PRO

EBITDA

₹ GET PRO

Net Profit

₹ GET PRO

Networth

-75.65%

₹ GET PRO

Borrowings

92056.86%

₹ GET PRO

Assets

-41.41%

₹ GET PRO

Gross Margin

-27.98

GET PRO %

Operating Margin

-444.85

GET PRO %

Net Profit Margin

-280.41

GET PRO %

Return on Equity

-267.43

GET PRO %

ROCE

-223.96

GET PRO %

Debt to Equity

0.38

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (2)

State	Type	Address

Locations on Map

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Financial Highlights

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2023	Mar 2024
Equity Capital	32.5	32.5
Reserves	480.3	93.3
Borrowings +	-	47.0
Long term borrowings	-	-
Short term borrowings	-	47.0
Trade payables +	148.3	142.3
Days payable	2,447.0	1,846.0
Other liabilities +	317.3	342.3
Other non-current liabilities	138.4	124.2
Other current liabilities	30.6	75.8
Total liabilities	830.1	515.0
Fixed Assets +	132.7	151.3
Tangible assets	105.4	107.3
CWIP	27.0	43.8
Intangible assets	0.3	0.2
LT loans and advances	-	-
Other non-current assets	242.4	94.3
Current assets +	455.0	269.4
Inventories	-	-
Trade receivables	32.7	15.5
Cash and cash equivalents	0.6	5.3
ST loans and advances	0.5	0.2
Other current assets	421.1	248.3
Total assets	830.1	515.0

Percentage of assets	Mar 2023	Mar 2024
Equity Capital	3.91	6.3
Reserves	57.86	18.12
Borrowings +	0.01	9.13
Long term borrowings	0.0	0.0
Short term borrowings	0.01	9.13
Trade payables	17.86	27.63
Other liabilities +	38.22	66.46
Other non-current liabilities	16.67	24.12
Other current liabilities	3.69	14.71
Total liabilities
Fixed Assets +	15.99	29.38
Tangible assets	12.7	20.84
CWIP	3.25	8.5
Intangible assets	0.04	0.04
LT loans and advances	0.0	0.0
Other non-current assets	29.2	18.31
Current assets +	54.81	52.3
Inventories	0.0	0.0
Trade receivables	3.94	3.02
Cash and cash equivalents	0.07	1.03
ST loans and advances	0.06	0.04
Other current assets	50.73	48.21
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Sales growth %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2023	Mar 2024
Sales +	238.8	75.5
Sales growth %	None	-68.36
Expenses +	472.2	491.8
Cost of goods	22.1	28.1
Employee cost	106.7	141.5
Other costs	324.0	308.0
Operating profit +	-214.1	-402.1
Operating margin %	-89.7	-532.3
Other income	10.9	29.5
Interest	7.6	1.7
Depreciation	11.8	12.5
Exceptional items	-	-
Profit before tax	-222.6	-386.8
Tax	-	0.4
Profit - disc. ops	-	-
Net profit	-222.6	-387.2
Net margin %	-89.2	-368.7

Precentage of total income	Mar 2023	Mar 2024
Sales	95.64	71.94
Expenses +	189.16	468.36
Cost of goods	8.86	26.79
Employee cost	42.73	134.76
Other costs	129.79	293.28
Operating profit	-85.74	-382.9
Other income	4.36	28.06
Interest	3.06	1.61
Depreciation	4.71	11.91
Exceptional items	0.0	0.0
Profit before tax	-89.16	-368.36
Tax	0.0	0.36
Profit - disc. ops	0.0	0.0
Net profit	-89.16	-368.72

Revenue from operations

Ratios

Standalone

Consolidated

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Debt/Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Assets/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Liquidity +
Current Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Quick Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest Coverage	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Performance
Gross Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return +
Return on Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROCE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return on Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROIC	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Efficiency +
Days Payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Inventory	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Receivable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital
Cash Conversion Cycle	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital Days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	0.0	0.4
Net Debt/Equity	0.0	0.3
Total Debt/Assets	0.0	0.1
Total Assets/Equity	1.6	4.1
Liquidity +
Current Ratio	2.5	1.0
Quick Ratio	2.5	1.0
Interest Coverage	-28.0	-237.3
Performance
Gross Margin	90.7	62.8
Operating Margin	-89.7	-532.3
Net Margin	-89.2	-368.7
Return +
Return on Equity	-43.4	-307.9
Pre-tax ROCE	-55.2	-266.4
Return on Assets	-26.8	-75.2
Pre-tax ROIC	-44.0	-247.6
Efficiency +
Days Payable	2,447.0	1,846.0
Days Inventory	0.0	0.0
Days Receivable	50.0	75.0
Fixed Asset Turnover	1.8	0.5
Total Asset Turnover	0.3	0.1
Working Capital
Cash Conversion Cycle	-2,397.0	-1,771.0
Working Capital Days	422.0	21.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

Kotak Mahindra Bank Limited

No. of Loans: 1

Total Amount : 150.0 cr

ICICI Bank Limited

No. of Loans: 1

Total Amount : 25.0 cr

Charge Holder	Amount	Date of creation/modification
Kotak Mahindra Bank Limited	150.0 cr	12 Apr, 2024
ICICI Bank Limited	25.0 cr	17 Mar, 2022

Charges

Kotak Mahindra Bank Limited

ICICI Bank Limited

People

Designation	Name	DIN/PAN	Tenure
Director	Sudhir Vrundavandas Valia Shareholder	00005561	11 years
Managing Director	Dilip Shantilal Shanghvi Shareholder	00005588	19 years
CFO	Chetan Manharlal Rajpara Shareholder	<HIDDEN>	8 years
Director	Ferzaan Nariman Engineer	00025758	8 years
Director	Bhavna Gautam Doshi	00400508	11 years
Director	Rajamannar Thennati Shareholder	01415412	18 years
Kmp	Anil Kumar	<HIDDEN>	4 years
Kmp	Kajal Kiran Damania	<HIDDEN>	2 years
Director	Robert Jay Spiegel	08739625	5 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
ITI MUTUAL FUND TRUSTEE PRIVATE LIMITED	Active	50.0 L	1	Maharashtra
SHANTILAL SHANGHVI FOUNDATION	Active	0.0	2	Maharashtra
KRISHNA VRUNDAVAN PRATISHTHAN	Active	0.0	1	Maharashtra
SUN PHARMA DRUGS PRIVATE LIMITED	Amalgamated	20.0 Cr	2	Maharashtra
VENERATE PROPERTIES PRIVATE LIMITED	Active	1.0 L	1	Maharashtra
EKLAVYA SECURITIES LIMITED	Amalgamated	20.0 L	1	Maharashtra
ALFA INFRAPROP PRIVATE LIMITED	Active	1.4 Cr	2	Maharashtra
SEJRAJ FINANCIAL SERVICES LIMITED	Converted to LLP and Dissolved	5.0 L	1	Maharashtra
ITI MANAGEMENT ADVISORS LIMITED	Amalgamated	217.4 Cr	1	Maharashtra
ADITYA CLEAN POWER VENTURES PRIVATE LIMITED	Active	1.0 L	2	Maharashtra
NISHA CAPITAL SERVICE LIMITED	Amalgamated	5.0 L	1	Maharashtra
MINAXI FISCAL SERVICES PRIVATE LIMITED	Amalgamated	1.0 L	1	Maharashtra
ADITYA THERMAL ENERGY PRIVATE LIMITED	Active	68.0 L	1	Maharashtra
LAKSHDEEP INFRASTRUCTURE AND HOLDING PRIVATE LIMITED	Active	1.0 L	1	Delhi
TOPLINK ADVISORS LLP	Active	1.0 L	1	Maharashtra
INIZIO INVESTRADE LLP	Active	1.0 L	1	Maharashtra
REBUS ADVISORS AND INVESTRADE LLP	Active	1.0 L	1	Maharashtra
EXPEDIENT MULTITRADE LLP	Active	1.0 L	1	Maharashtra
THIRDWAVE MULTITRADE LLP	Active	5.0 L	1	Maharashtra
NEOSTAR DEVELOPERS LLP	Active	1.0 L	1	Maharashtra
SURAKSHA ASSET RECONSTRUCTION LIMITED	Active	210.0 Cr	1	Maharashtra
FASTTRACK HOUSING FINANCE LIMITED	Active	62.6 L	1	Maharashtra
SUN PETROCHEMICALS PRIVATE LIMITED	Active	9.2 Cr	2	Gujarat
JAYPEE INFRATECH LIMITED	Active	125.0 Cr	1	Uttar Pradesh
SUN PHARMACEUTICAL INDUSTRIES LIMITED	Active	239.9 Cr	2	Gujarat
SUN PHARMA MEDICATION PRIVATE LIMITED	Amalgamated	20.0 Cr	1	Maharashtra
TRICLINIUM CLINICAL DEVELOPMENT PRIVATE LIMITED	Strike Off	20.0	1	Gujarat
CYTESPACE RESEARCH PRIVATE LIMITED	Active	5.4 L	1	Gujarat
CYTECARE HOSPITALS PRIVATE LIMITED	Active	43.4 L	1	Gujarat
THE GREAT EASTERN SHIPPING COMPANY LIMITED	Active	142.8 Cr	1	Maharashtra
INDIAN MERCHANTS CHAMBER	Active	0.0	1	Maharashtra
GREATSHIP (INDIA ) LIMITED	Active	111.3 Cr	1	Maharashtra
GRUH FINANCE LIMITED	Amalgamated	146.8 Cr	1	Gujarat
CONNECT INFOTAIN PRIVATE LIMITED	Converted to LLP	10.0 L	1	Maharashtra
CONNECT CAPITAL PRIVATE LIMITED	Active	1.1 Cr	1	Maharashtra
ICAI ACCOUNTING RESEARCH FOUNDATION	Active	0.0	1	Delhi
BHAVNA DOSHI ASSOCIATES LLP	Active	1.0 L	1	Maharashtra
INDUSIND BANK LTD.	Active	779.0 Cr	1	Maharashtra
KPIT TECHNOLOGIES LIMITED	Active	274.1 Cr	1	Maharashtra
ALKYL AMINES CHEMICALS LIMITED	Active	10.2 Cr	1	Maharashtra
NUVOCO VISTAS CORPORATION LIMITED	Active	357.2 Cr	1	Maharashtra

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
SPARCLIFE Inc.	United States	-	-

Registered Details

CIN

L73100GJ2006PLC047837

PAN

AAJCS8340R

Incorporation

2006, 19.2 years

Company Email

secretarial@sparcmail.com

Paid up Capital

₹ 32.5 Cr

Authorised Capital

₹ 42.5 Cr

AGM

Aug 2023

Type

Public

Non-government Company

FAQ - SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED

What is the incorporation date of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED?

The incorporation date of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is 01 March, 2006

What is the authorized share capital of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED?

The authorized share capital of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is INR ₹ 42.5 Cr.

What is the paid-up capital of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED?

The paid-up capital of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is INR ₹ 32.5 Cr.

What is the registered address of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED?

The registered address of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is Plot No. 5 & 6/1, Savli G.I.D.C. Estate, Savli – Vadodara Highway Manjusar Vadodara Gujarat - 391775

What is the CIN number of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED?

The CIN number of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is L73100GJ2006PLC047837.

Smart Suggestions

Top Blog Post

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

People

Company Network